Fundraising FoxTinos Therapeutics
Cambridge, US · Founded 2023 · Delaware corporation
Find your way into Tinos Therapeutics
Sign up to see every warm intro you have to Tinos Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tinos Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tinos Tx develops first-in-class small molecule inhibitors targeting the RNA demethylase FTO to destabilize tumor-driving RNA and kill cancer cells. The company builds on research into how RNA methylation controls cellular survival to create cancer therapeutics.
Founders & leadership
DK
David KarambiziNamed on SEC filing
NT
Nikolaos TapinosNamed on SEC filing
Board
AP
Anastasios PolimenakosBoard director
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 round · 2025
▶$2.3MraisedApr 2026 · 3 investors · BiotechnologyRule 506(b)
▶$2.3MraisedApr 2026 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David KarambiziExecutive Officer, Director
- Anastasios PolimenakosDirector
- Nikolaos TapinosExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.3M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Tinos Therapeutics do?
- Tinos Tx develops first-in-class small molecule inhibitors targeting the RNA demethylase FTO to destabilize tumor-driving RNA and kill cancer cells. The company builds on research into how RNA methylation controls cellular survival to create cancer therapeutics.
- How much funding has Tinos Therapeutics raised?
- Tinos Therapeutics has disclosed $2.3M raised across 1 round.
- Where is Tinos Therapeutics headquartered?
- Tinos Therapeutics is headquartered in Cambridge, US.